Committee Members

Saba Beigh is an Assistant Professor of Toxicology and Pharmacology at Al-Baha University, Saudi Arabia. She holds a PhD from Jamia Hamdard University, India, and completed a postdoctoral fellowship in Nanotoxicology at the University of Strasbourg, France. Her research focuses on pulmonary toxicity from anticancer drugs, molecular pharmacology, and the therapeutic potential of natural compounds. She has expertise in molecular biology, oxidative stress analysis, immunohistochemistry, and animal model studies. Dr. Beigh has received multiple awards, including the CSIR-SRF fellowship and the Best Poster Award at EUROTOX. She is an active member of STOX and SFRR and has published extensively in high-impact journals. Her work spans pulmonary toxicology, computational drug design, neuropharmacology, and epidemiological studies. She also serves as a reviewer and editorial board member for international journals.

Michele Tomasicchio is a Senior Researcher at the University of Cape Town in South Africa. His work primarily focuses on infectious diseases, including tuberculosis and COVID-19. Dr. Tomasicchio has contributed to significant research on the safety and efficacy of vaccines, such as the ChAdOx1 nCoV-19 vaccine (AZD1222), in collaboration with institutions like the Liverpool University Hospitals NHS Foundation Trust. Additionally, he has been involved in studies evaluating diagnostic tools for tuberculosis, working alongside the Liverpool School of Tropical Medicine. His extensive research portfolio includes over 39 publications with numerous citations, reflecting his impact in the field of infectious diseases.

Javed Ahsan is a researcher and academic at the University of Liverpool, dedicated to advancing knowledge through research, teaching, and collaboration. With expertise in his field, he has contributed to various projects, publications, and academic initiatives. His work focuses on exploring new ideas, solving complex problems, and engaging with the academic community to drive innovation. As an active scholar, he continues to participate in research endeavors, fostering collaboration with peers and institutions. He is committed to academic excellence and the pursuit of new discoveries.

Fenyong Liu is a Professor of Infectious Diseases at UC Berkeley, specializing in virology, antiviral drug development, and RNA biochemistry. His research focuses on cytomegalovirus (CMV), herpesviruses, and HIV, aiming to develop novel antiviral therapies. Born in Guangzhou, China, he pursued his undergraduate studies at the University of Science and Technology of China. Dr. Liu has published extensively, with over 7,900 citations in microbiology and infectious diseases. He is also highly regarded for his teaching excellence and mentorship at Berkeley.

Alice Elena Ghenea is a Lecturer at the University of Medicine and Pharmacy of Craiova in Romania, specializing in antibiotic drug resistance and artificial intelligence applications in medicine. She has authored 33 publications, accumulating over 270 citations, and has contributed to research on infections caused by Klebsiella species and the impact of the COVID-19 pandemic on antibiotic resistance in Gram-negative pathogens. Dr. Ghenea is also recognized for her work on clinical and biochemical parameters in assessing chronic hepatitis B patients undergoing antiviral therapy.

Sudha Yellapantula is a researcher with a Ph.D. in Electrical and Computer Engineering from Rice University. Her work focuses on signal processing, information theory, and neuroscience, particularly in understanding human language organization in the brain to aid individuals with language disorders. She has contributed to studies on brain dynamics using graph theory and data-driven causality measurements. Dr. Yellapantula has published several papers in her field, with her work cited over 200 times. Additionally, she has been involved in fundraising efforts for pediatric cancer research, notably participating in the 2019 Great Cycle Challenge.